Monsha'at Reports 3.5% Quarterly Increase in SMEs Driven by Growth across Saudi Non-Oil Economy

Monsha'at released its latest quarterly SME Monitor, which showed a 3.5% growth in the number of SMEs in Saudi Arabia in Q3 2023, bringing their total number to 1.27 million.
Monsha'at released its latest quarterly SME Monitor, which showed a 3.5% growth in the number of SMEs in Saudi Arabia in Q3 2023, bringing their total number to 1.27 million.
TT

Monsha'at Reports 3.5% Quarterly Increase in SMEs Driven by Growth across Saudi Non-Oil Economy

Monsha'at released its latest quarterly SME Monitor, which showed a 3.5% growth in the number of SMEs in Saudi Arabia in Q3 2023, bringing their total number to 1.27 million.
Monsha'at released its latest quarterly SME Monitor, which showed a 3.5% growth in the number of SMEs in Saudi Arabia in Q3 2023, bringing their total number to 1.27 million.

The General Authority for Small and Medium Enterprises (Monsha'at) has released its latest quarterly SME Monitor, which showed a 3.5% growth in the number of SMEs in Saudi Arabia in Q3 2023, bringing their total number to 1.27 million.

With over 40,000 new businesses created across the country in Q3, the monitor indicated that 43.3% of SMEs are now located in the booming financial capital of Riyadh. The Saudi economy, driven by strong non-oil growth of 3.6% in Q3, is now expected to expand by 0.8% in 2023, according to the IMF, outpacing average G20 growth.

Highlighting trends across the broader Saudi economy, the latest monitor contained sections on the Kingdom's expanding manufacturing sector, which grew by 4.6% year-on-year in Q3 2023, according to the General Authority for Statistics (GASTAT).

With Saudi Arabia aiming to establish itself as a leading industrial and manufacturing hub, a series of large public initiatives driven in part by the National Industrial Development and Logistics Program (NIDLP) helped more SMEs enter these spaces in Q3 2023, the monitor added.

With over 11,000 factories now operating in the Kingdom, 136 new industrial licenses were issued by the Ministry of Industry and Mineral Sources alone in August 2023.

According to the monitor, SMEs have also shown considerable progress in Al-Qassim Province, particularly in mining and agriculture. With nearly 60,000 SMEs, Al-Qassim has 105 active mining licenses.

While its mining industry produces 4 million tons of bauxite each year, the only such source in the Middle East, the region's farmers produce 1.22 million tons of dates, lemons, oranges, grapes, and other agricultural products each year, giving credence to its nickname as the breadbasket of the Kingdom.

Throughout the quarter, SMEs also continued to benefit from a diverse range of innovative upskilling programs, as detailed in the monitor.

Monsha'at hosted five week-long upskilling events to help SMEs attract funding, expand their business, and enter the commercial franchise, healthcare, and legal sectors. Throughout Q3, more than 100,000 SMEs benefitted from one of Monsha'at's programs.

According to the monitor, the private sector continued to propel the Saudi economy in Q3 2023 due to these and other initiatives.

Buoyed by robust private sector investment in SMEs, which increased year-on-year by 18.8% in Q2 2023 to SAR262.7 billion ($70 billion), the Kingdom's non-oil growth is a symptom of a rapidly maturing ecosystem whose entrepreneurs are now driving Saudi Arabia's ambitious diversification targets.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.